Sage Therapeutics, Inc.

James J Doherty

Bret Berner

Paul Steven Watson

John Gregory Reid

Stephen Jay Kanes

Jian Wang

Gabriel Martinez Botella

Michael C Quirk

This invention relates to a crystalline 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I), and compositions thereof. Also disclosed herein are methods of making the same and methods of using the same.

Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid

This invention relates to a 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I) and crystalline solid forms and compositions thereof. Also disclosed herein are methods of making crystalline solid forms of the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I) and methods of using the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I) or crystalline solid forms, pharmaceutically acceptable salts, and pharmaceutically acceptable compositions thereof. 

Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid

Growing community of inventors

Bedford, MA, United States of America

James J Doherty